Management

Gareth Sheridan is an award winning entrepreneur, businessman and founder of Nutriband inc.  Mr. Sheridan currently sits as CEO of Nutriband Inc.   Mr. Sheridan was Ireland’s ‘Young Entrepreneur of the Year’ in 2014 for establishing Nutriband Ltd. And with it Nutriband was awarded Ireland’s ‘Best New Product 2014’.  Mr. Sheridan has further business awards from S. Dublin’s Best Young Entrepreneur and S. Dublin’s Best Startup Company.   Mr. Sheridan has also worked as a Business Mentor with 100 Minds, a social enterprise founded in 2013, that brings together some of Ireland’s top college students and connects them with one cause to achieve large charitable goals in a short space of time.   Mr. Sheridan is also a past Nissan Generation Next Ambassador, receiving the acknowledgement in 2015 by Nissan Ireland as one of Ireland’s future generational leaders.   Mr. Sheridan received a B.Sc. in Business and Management from Dublin Institute of Technology in 2012. Where he concentrated on international economics, venture creation and entrepreneurship.

Sean Gallagher is an experienced businssman, an inspiring speaker & a highly regarded business writer. He also stood, as an Independent Candidate, and was runner up, in the 2011 Irish Presidential Election.  Sean’s notable business ventures include Co Founding and serving as CEO of Clyde Real Estate, Pharmaceutical Directorships and co-founding Ireland’s largest home technology company, Smarthomes.  Sean has also served as a investor in popular TV show, Dragon’s Den which is Ireland and UK’s version of popular US TV show Shark tank.   Sean qualified with an MBA from the University of Ulster and previously worked with one of Ireland’s Enterprise Agencies and has, over the past 20 years, trained and mentored hundreds of emerging entrepreneurs. He has also served on a number of Irish State Boards including the National Training and Employment Agency (FAS), the North South Trade Body (InterTrade Ireland) and was Chair of the State owned Drogheda Port Company.

Mr. Melnik has been involved in general business consulting for companies in the U.S. financial markets and setting up legal and financial framework for operations of foreign companies in the U.S.   Mr. Melnik advised UNR Holdings, Inc. with regard to the initiation of the trading of its stock in the over-the-counter markets in the U.S., and has provided general advice with respect to the U.S. financial markets for companies located in the U.S. and abroad.  From February 2003 to May 2005 he was the Chief Operations Officer and a Board member of Asconi Corporation, Winter Park, Florida, with regard to restructuring the company and listing it on the American Stock Exchange.   Mr. Melnik from June 1995 to December 1996 was a lawyer in the Department of Foreign Affairs, JSC Bank “Inteprinzbanca,”, Chisinau, Moldova, and prior thereto practiced law in Moldova in various positions. Mr. Melnik is fluent in Russian, Romanian, English and Spanish.

Ray Kalmar is the Chief Innovation Officer of Nutriband Inc. and Global Head of Pharmaceutical Development and Bio-Medicines. Before he joined Nutriband in April 2017, he had most recently served as Founder and CEO of Advanced Health Brands Corporation.   Ray served in the United States Air Force for 12 Years, 8 years in Air Force Special Ops and 4 years as a combat medic, completing two tours in Iraq during his service. He stays active in the veteran community by volunteering with Team Red, White and Blue and Team Rubicon.   Ray worked at Schering-Plough and Merck from 1999 to 2009 in sales and marketing roles, and he later held a series of increasingly responsible roles at Merck, Harvard Drug and Letco Medical. He has over 18 years’ experience in pharmaceuticals, bulk chemicals and pharmacogenetics. His primary focuses have been cardiovascular disease, pulmonary disease and infectious disease.

lan Smith, Ph.D., co-founded 4P Therapeutics in 2011 and serves as Vice President, Clinical, Regulatory, Quality, and Operations. Previously, he was with Altea Therapeutics, most recently serving as Vice President, Product Development and Head of Clinical R&D, Regulatory Affairs, and Project Management. At Altea, he led major research and development programs with pharmaceutical companies such as Eli Lilly, Amylin, Hospira, Elan, and Novartis. He joined Altea as one of the first employees and spent 12 years growing its multidisciplinary drug delivery research and development organization. Dr. Smith has 20 years of experience in the research and development of drug and biologic delivery systems, diagnostics and medical devices for treatment and management of diabetes, chronic pain and cardiovascular disease. Prior to joining Altea Therapeutics, he led the development of transdermal glucose monitoring systems at SpectRx, Inc., a publicly traded noninvasive diagnostics company. Dr. Smith received Ph.D. and M.S. degrees in Biomedical Engineering from Rutgers University and the University of Medicine and Dentistry of New Jersey. He currently serves on the Editorial Advisory Board of Expert Opinion on Drug Delivery.

Paddy Ryan joined the Nutriband team in February 2018. Coming from an Engineering background, and having worked in the tech industry for 8 years, Paddy brings a fresh perspective and understanding to our team.   As CTO, Paddy is responsible for Nutriband’s technology strategy and plays a key role in leading new initiatives.

Paul Murphy is the Chief Operations Officer of Nutriband Inc. Before joining Nutriband in April 2017, Paul served as Founder and COO of Advanced Health Brands Corporation.   Paul brings 20 years of sales and management experience to Nutriband Inc.  Paul has ten years as an executive with a bulk chemical provider for the Midwest consisting of Michigan, Indiana, Ohio, Illinois, Wisconsin, Tennessee and Kentucky. Paul specialized in CAD cleanroom and sterile lab design for US pharmacy compounding market for USP 795, USP 797 and USP 800 regulations. Paul consulted within the emerging Outsourcing Facility (503B) market with cGMP requirements for manufacturing. Mr. Murphy received his Bachelor of Applied Arts from Central Michigan University.

Ms. Fillman is a finance and commercial executive with 25+ years’ experience.  Her experience includes treasury, finance, investments, business development and contract negotiation. In finance, Ms.Fillman worked extensively with Wall Street and investor relations.  Specific areas of responsibility have included establishing a credit facility, trading derivatives, managing investment portfolios, managing liquidity and capital structure, developing budgets, and repatriating foreign earnings.  While in finance, Ms. Fillman traveled internationally as part of an M&A team.   As a contracts negotiator, Ms. Fillman has negotiated contracts for Fortune 100 companies in a multitude of industries and geographies.  She has led cross-functional teams in deal analysis and strategy development for a variety of agreement-types, including global service agreements, royalty agreements and joint ventures.   Ms. Fillman has an MBA in Finance and an BA with honors in economics.

As President of Asia in charge of Nutriband Inc., Mr. Lee specializes in unique marketing aspect of Asian market and its distribution system in both South Korea and Taiwan for Nutriband and business exclusivity, distribution partnership and sales strategies in Asian region. Mr. Lee has over 24 years of experience in nutritional supplement industry. He is the founder and CEO of Edge Mark Innovation Inc. (EMI), and EMI Korea, a nutritional marketing and distribution company in USA and founder of puRA Labs an Essential oil manufacture which distribute in both U.S. and Asia. Past he has representing industries top companies like Douglas Labs, Pure encapsulations, Mucus Pharma (Wobenzym), Tropics, and Bio-K. Mr. Lee holds a Bachelor of Arts Degree in Economics from University of California Los Angeles and Bachelor of Arts Degree in Marketing from California State Long Beach. He has also completed specific coursework covering the financial analysis of distribution and International distribution channel system and numerous continuing education classes in nutrition, marketing and wholefood-based science valuation. In addition, he has completed the American Essential Oil Trade Association course and IFRA North America member.

Jeff Patrick Pharm.D. currently serves as Director of Drug Development Institute at the Ohio State UniversityComprehensive Cancer Center. Dr. Patrick most recently serving as Chief Scientific Officer for New Haven Pharmaceuticals. Prior roles included global vice president of professional affairs at Mallinckrodt Pharmaceuticals, Inc.; and roles with ascending responsibilities at Dyax, Myogen/Gilead, Actelion and Sanofi-Synthelabo, Inc.   Dr. Patrick is a residency-trained clinical pharmacist with approximately 20 years of pharmaceutical industry experience. He brings expertise in executive leadership, scientific and medical strategy, drug development and commercialization to the company.   Prior to pursuing a career in research and development, Patrick was an ambulatory care clinical pharmacist at the University of Tennessee Medical Center and a clinical assistant professor of pharmacy at the University of Tennessee College of Pharmacy, where he earned his doctorate in pharmacy. He also completed the Wharton School of Business Pharmaceutical Executive Program.